Economic evaluations of radioembolization with yttrium-90 microspheres in liver metastases of colorectal cancer: a systematic review

被引:0
作者
JC Alonso
I Casans
FM González
D Fuster
A Rodríguez
N Sánchez
I Oyagüez
AO Williams
N Espinoza
机构
[1] Hospital Gregorio Marañón,Nuclear Medicine Department
[2] Hospital Clínico Universitario,Nuclear Medicine Department
[3] Hospital Universitario Central,Nuclear Medicine Department
[4] Hospital Clinic,Nuclear Medicine Department
[5] Hospital Virgen de las Nieves,Nuclear Medicine Department
[6] Pharmacoeconomics & Outcomes Research Iberia (PORIB),undefined
[7] Boston Scientific Marlborough,undefined
来源
BMC Gastroenterology | / 23卷
关键词
Colorectal cancer; Cost; Radioisotope therapy; Systematic review; Yttrium-90;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 165 条
[1]  
Benson AB(2021)Colon cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology J Natl Compr Canc Netw 19 329-59
[2]  
Venook AP(2017)The cost of colorectal cancer according to the TNM stage Cir Esp 95 89-96
[3]  
Al-Hawary MM(2016)ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Ann Oncol 27 1386-422
[4]  
Arain MA(2020)Treatment of patients with late-stage colorectal Cancer: ASCO Resource-Stratified Guideline JCO Glob Oncol 6 414-38
[5]  
Chen Y-J(2013)Radioembolization for treatment of salvage patients with colorectal cancer liver metastases: a systematic review J Nucl Med Off Publ Soc Nucl Med 54 1890-5
[6]  
Ciombor KK(2014)Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy Eur J Nucl Med Mol Imaging 41 1861-9
[7]  
Mar J(2021)Dose-Effect Relationships of 166Ho Radioembolization in Colorectal Cancer J Nucl Med Off Publ Soc Nucl Med 62 272-9
[8]  
Errasti J(2020)Health Economic Models for metastatic colorectal Cancer Methodological Rev PharmacoEconomics 38 683-713
[9]  
Soto-Gordoa M(2016)90Y Radioembolization of Colorectal hepatic metastases using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study J Nucl Med Off Publ Soc Nucl Med 57 665-71
[10]  
Mar-Barrutia G(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 b2535-5